Perioperative cimetidine administration promotes peripheral blood lymphocytes and tumor infiltrating lymphocytes in patients with gastrointestinal cancer: Results of a randomized controlled clinical trial | Zendy

Congyao Lin | Zendy; De-jiao Bai | Zendy; Yuan Hong-yin | Zendy; Kun Wang | Zendy; Guoliang Yang | Zendy; Ming-Bai Hu | Zendy; Zhou-Qing Wu | Zendy; Yan Li | Zendy

Open Access

Perioperative cimetidine administration promotes peripheral blood lymphocytes and tumor infiltrating lymphocytes in patients with gastrointestinal cancer: Results of a randomized controlled clinical trial

Author(s) -

Congyao Lin,

De-jiao Bai,

Yuan Hong-yin,

Kun Wang,

Guoliang Yang,

Ming-Bai Hu,

Zhou-Qing Wu,

Yan Li

Publication year - 2004

Publication title -

world journal of gastroenterology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.427

H-Index - 155

eISSN - 2219-2840

pISSN - 1007-9327

DOI - 10.3748/wjg.v10.i1.136

Subject(s) - medicine , tumor infiltrating lymphocytes , perioperative , immunology , cancer , monoclonal antibody , antibody , gastroenterology , immunotherapy , surgery

To study the effects of perioperative administration of cimetidine (CIM) on peripheral blood lymphocytes, natural killer (NK) cells and tumor infiltrating lymphocytes (TIL) in patients with gastrointestinal (GI) cancer.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research